PET is necessary to make the next step forward in understanding MS pathophysiology

Abstract

Get full access to this article

View all access options for this article.

References

Filippi

Bar-Or

Piehl

et al . Multiple sclerosis. Nat Rev Dis Primers 2018; 4: 43.

Filippi

Rocca

Barkhof

et al . Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol 2012; 11: 349–360.

Hogel

Rissanen

Vuorimaa

et al . Positron emission tomography imaging in evaluation of MS pathology in vivo. Mult Scler 2018; 24: 1399–1412.

Herranz

Gianni

Louapre

et al . Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol 2016; 80: 776–790.

Bodini

Veronese

Garcia-Lorenzo

et al . Dynamic imaging of individual remyelination profiles in multiple sclerosis. Ann Neurol 2016; 79: 726–738.

Turkheimer

Rizzo

Bloomfield

et al . The methodology of TSPO imaging with positron emission tomography. Biochem Soc Trans 2015; 43: 586–592.

Tronel

Largeau

Santiago Ribeiro

et al . Molecular targets for PET imaging of activated microglia: The current situation and future expectations. Int J Mol Sci 2017; 18: E802.

Pike

VW.

PET radiotracers: Crossing the blood-brain barrier and surviving metabolism. Trends Pharmacol Sci 2009; 30: 431–440.

Hogel

Rissanen

Vuorimaa

et al . Positron emission tomography imaging in evaluation of MS pathology in vivo. Mult Scler 2018; 24: 1399–1412.

10.

Levine

McDonald

Kressel

HY.

Gadolinium retention after contrast-enhanced MRI. JAMA 2018; 320: 1853–1854.

PET is necessary to make the next step forward in understanding MS pathophysiology – No

Abstract

Get full access to this article

References